Development of a Flow Cytometry Assay to Predict Immune Checkpoint Blockade-Related Complications

Treatment of advanced melanoma with combined immune checkpoint inhibitor (ICI) therapy is complicated in up to 50% of cases by immune-related adverse events (irAE) that commonly include hepatitis, colitis and skin reactions. We previously reported that pre-therapy expansion of cytomegalovirus (CMV)-...

Descripción completa

Detalles Bibliográficos
Autores principales: Schilling, Hannah-Lou, Glehr, Gunther, Kapinsky, Michael, Ahrens, Norbert, Riquelme, Paloma, Cordero, Laura, Bitterer, Florian, Schlitt, Hans J., Geissler, Edward K., Haferkamp, Sebastian, Hutchinson, James A., Kronenberg, Katharina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637156/
https://www.ncbi.nlm.nih.gov/pubmed/34868015
http://dx.doi.org/10.3389/fimmu.2021.765644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637156/
https://www.ncbi.nlm.nih.gov/pubmed/34868015
http://dx.doi.org/10.3389/fimmu.2021.765644

Ejemplares similares